Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
11/2013
11/05/2013US8575344 Process for preparing voriconazole by using new intermediates
11/05/2013US8575341 Cosmetic composition, cosmetic treatment method, and compound
11/05/2013US8575338 Pyrimidine, pyridine and triazine derivatives as maxi-K channel openers
11/05/2013US8575197 Pyrolinone derivative and pharmaceutical composition comprising the same
11/05/2013US8575173 Piperazinyl 3-aminopyrrolidine derivatives as a CCR2 antagonists
11/05/2013US8575163 Pyrrolopyridinylpyrimidin-2-ylamine derivatives
11/05/2013US8575149 5HT2C receptor modulators
11/05/2013US8575118 Antiviral compounds
11/05/2013US8574563 Hepatitis C virus inhibitors
11/05/2013CA2731403C Pyrrolidin-3-ylmethyl-amine as orexin antagonists
11/05/2013CA2633207C Pyrazinecarboxamide derivatives and plant disease controlling agents containing the same
11/05/2013CA2600169C Pyrazine -2-carboxamide derivatives as mglur5 antagonists
11/05/2013CA2594345C Compositions and methods of treating cell proliferation disorders
11/05/2013CA2491994C Modulators of the glucocorticoid receptor
10/2013
10/31/2013WO2013163262A1 Piperazine-piperidine compounds as hepatitis c virus inhibitors
10/31/2013WO2013163190A1 Dna-pk inhibitors
10/31/2013WO2013162284A1 Novel organic electroluminescent compounds and organic electroluminescent device comprising the same
10/31/2013WO2013162072A1 Tetrazolinone compounds and its use as pesticides
10/31/2013WO2013161904A1 Sulfonamide derivative and medicinal use thereof
10/31/2013WO2013161853A1 Quinazolinedione derivative
10/31/2013WO2013161851A1 Benzamide derivative
10/31/2013WO2013160808A1 Labelled quinoxaline derivatives as multimodal radiopharmaceuticals and their precursors
10/31/2013WO2013160126A1 Pyridazinone herbicidal compounds
10/31/2013WO2013134047A3 Aminoquinoline derivatives and uses thereof
10/31/2013WO2013121334A3 Agents for treating neurodegenerative disorders
10/31/2013WO2002064559A3 Thrombin inhibitors
10/31/2013US20130289086 Aminopyrrolidinone Derivatives and Uses Thereof
10/31/2013US20130289085 Histone deacetylase (hdac) inhibitors targeting prostate tumors and methods of making and using thereof
10/31/2013US20130289075 Iap binding compounds
10/31/2013US20130289072 Novel indole or indazole derivative or salt thereof
10/31/2013US20130289050 Inhibitors of beta-secretase
10/31/2013US20130289048 Cyclohexane derivative compound
10/31/2013US20130289044 Quinazoline Compounds as Sodium Channel Blockers
10/31/2013US20130289042 Dimeric iap inhibitors
10/31/2013US20130289041 Quinoxaline compounds and uses thereof
10/31/2013US20130289025 Pyrazole-substituted arylamides as p2x3 and p2x2/3 antagonists
10/31/2013US20130289016 Pyrimidinyl and 1,3,5-triazinyl benzimidazole sulfonamides and their use in cancer therapy
10/31/2013US20130289003 Diazeniumdiolate heterocyclic derivatives
10/31/2013DE59209330C5 Benzimidazole, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung Benzimidazoles, pharmaceutical compositions containing them and methods for their preparation
10/30/2013EP2657232A2 Process for the purification of a benzenesulphonamide compound
10/30/2013EP2657231A2 Substituted azoles, anti-viral active ingredient, pharmaceutical composition, method for the production and use thereof
10/30/2013EP2657229A1 Benzyloxypyrimidine derivative, agricultural/horticultural insecticide comprising derivative and method for using same
10/30/2013EP2657213A1 Labelled quinoxaline derivatives as multimodal radiopharmaceuticals and their precursors
10/30/2013EP2655399A1 Trypsin-like serine protease inhibitors, their preparation and use as selective inhibitors of the clotting factors iia and xa
10/30/2013EP2655378A1 Compounds and their use as bace inhibitors
10/30/2013EP2655372A2 Pyrroloquinolinyl-pyrrolidine-2,5-dione compositions and methods for preparing and using same
10/30/2013EP2655361A2 Method for producing triazinyl-substituted oxindoles
10/30/2013EP2655360A1 Method for producing n-sulfonyl-substituted oxindoles
10/30/2013EP2655359A1 Conjugated 3-(indolyl)- and 3-(azaindolyl)-4-arylmaleimide compounds and their use in tumor treatment
10/30/2013EP2655358A1 Oxindolopyrimidine as igf1r receptor inhibitors
10/30/2013EP2655357A1 Indazolyl triazole derivatives as irak inhibitors
10/30/2013EP2655356A1 Faah inhibitors
10/30/2013EP2655355A1 New triazolylphenyl sulfonamides as serine/threonine kinase inhibitors
10/30/2013EP2655347A1 Triazine derivatives for electronic applications
10/30/2013EP2655346A2 Method for producing 2-(triazinylcarbonyl) sulfonanilides
10/30/2013EP2655338A1 Benzoimidazole derivatives for use in light - emitting devices
10/30/2013EP2655331A1 Glucagon receptor modulators
10/30/2013EP2655327A1 Fluorescent compounds
10/30/2013EP2654750A1 Novel fused pyridine compounds as casein kinase inhibitors
10/30/2013EP2654748A1 Indazole derivatives useful as erk inhibitors
10/30/2013EP2654425A2 Ectoparasiticidal active substance combinations
10/30/2013EP2654422A1 Bicyclo[3.2.1]octyl amide derivatives and uses of same
10/30/2013CN103380133A Compounds and their use as BACE inhibitors
10/30/2013CN103380127A Method for producing N-sulfonyl-substituted oxindoles
10/30/2013CN103380126A Method for producing 2-(triazinylcarbonyl) sulfonanilides
10/30/2013CN103380125A Method for producing triazinyl-substituted oxindoles
10/30/2013CN103380112A Indole derivatives as modulators of S1P receptors
10/30/2013CN103373989A Preparation method of intermediate of pazopanib hydrochloride
10/30/2013CN103373988A 1, 2, 4-Triazole and pyrazine ring-containing acylhydrazone derivatives, preparation method and applications
10/30/2013CN103373987A Pyrazine ring-containing triazole derivatives, preparation method and applications
10/30/2013CN103373963A Intermediate of pazopanib hydrochloride and preparation method of intermediate of pazopanib hydrochloride
10/30/2013CN103372461A Chiral emulsion catalyst as well as preparation method and application thereof
10/30/2013CN102239164B 2H-chromene compound and derivative thereof
10/30/2013CN102219745B 2-aryl substituted benzimidazole derivatives, as well as preparation method and application thereof
10/30/2013CN102108078B 1,4-substituted phthalazine compound and preparation method and applications thereof
10/30/2013CN101855221B Pyridazinone derivatives as PARP inhibitors
10/30/2013CN101679358B Pyrrole derivatives as p2y12 antagonists
10/30/2013CN101426783B Cyclohexylpyrazole-lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
10/30/2013CN101323610B Preparation of trityl group candesartan cilexetil intermediate
10/30/2013CN101084215B Piperidine and azetidine derivatives as GLYT1 inhibitors
10/29/2013US8569528 Process for the preparation of tetrazole derivatives from organo boron and organo aluminium azides
10/29/2013US8569511 Substituted 3-(1H-benzo[d]imidazol-2-yl)-1H-indazole analogs as inhibitors of the PDK1 kinase
10/29/2013US8569506 Modified carbocyanine dyes and their conjugates
10/29/2013US8569488 Crystalline pyridazine compound
10/29/2013US8569485 Phenyl-substituted 1,3,5-triazine compound, process for producing the same, and organic electroluminescent device containing the same as component
10/29/2013US8569483 Process for the preparation of bazedoxifene acetate and intermediates thereof
10/29/2013US8569317 Aryl-quinazoline/aryl-2amino-phenyl methanone derivatives
10/29/2013US8569312 Biaryl-spiroaminooxzaoline analogues as alpha 2C adrenergic receptor modulators
10/29/2013US8569306 JNK modulators
10/29/2013US8569304 Active esters of N-substituted piperazine acetic acids, including isotopically enriched versions thereof
10/29/2013CA2563038C Neurologically-active compounds
10/24/2013WO2013158952A1 Isoindolone derivatives
10/24/2013WO2013158197A1 Marinopyrrole derivatives as anticancer agents
10/24/2013WO2013157886A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same
10/24/2013WO2013157540A1 Nitrogen-containing heterocyclic compound or salt thereof
10/24/2013WO2013157022A1 Substituted hetero-bicyclic compounds, compositions and medicinal applications thereof
10/24/2013WO2013156608A1 Amino-indolyl-substituted imidazolyl-pyrimidines and their use as medicaments
10/24/2013WO2013156559A1 N-cycloalkyl-n-[(heterocyclylphenyl)methylene]-(thio)carboxamide derivatives
10/24/2013WO2013156318A1 Substituted pesticidal pyrazole compounds
10/24/2013WO2013135671A9 Fungicidal pyrimidine compounds
1 ... 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 ... 626